United States
Australia
Brazil
Canada
Germany
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
The Lancet Respiratory Medicine in conversation with
From The Lancet Group
Health & Fitness
The Lancet Neurology in conversation with
by The Lancet Group
Today: #139 in Health & Fitness, Japan on our combined chart.
Share this ranking
Claiming needs an RSS feed. Contact us.
Chart positions today · India
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like The Lancet Neurology in conversation…, try…
The Lancet Psychiatry in conversation with
From The Lancet Group
JAMA Neurology Author Interviews
Similar topics: neurology and sclerosis
Neurology® Podcast
Similar topics: neurology and migraine
The Brain Podcast
Similar topics: sclerosis and disease
eanCast: Weekly Neurology
Similar topics: neurology and biomarkers
Ranking history · India
Latest daily rankings: Oct 22. New rankings will appear after the next update.
Recent history only — this show has no current ranking on the Health & Fitness, India chart. These are recorded positions from the last 7 days, not current rankings.
Position on the Health & Fitness, India combined chart over the last 7 days. Toggle platforms to compare their positions. Lower rank numbers are better.
View as table
| Date | Combined Rank | Apple Podcasts |
|---|---|---|
| Oct 22 | — | — |
| Oct 20 | #152 | #152 |
| Oct 17 | #196 | #197 |
Latest episodes
-
The future of Alzheimer’s disease: blood biomarkers, brain imaging, and screening the cognitively unimpaired
September 9, 2026 · 29 minWhat will Alzheimer’s disease diagnosis look like in 5–10 years? In this episode of In Conversation With…, Laura Hart is joined by the authors behind The Lancet Neurology Series on Future Directions in Alzheimer’s Disease and Related…
-
Marjo van der Knaap on vanishing white matter
August 12, 2026 · 17 minFor decades, a diagnosis of vanishing white matter disease came with no real treatment — so how is an old blood-pressure pill offering hope? In this episode of In Conversation With…The Lancet Neurology, Deputy Editor Laura Hart speaks with…
-
Jan D Lünemann and Christian Münz on Epstein–Barr virus and multiple sclerosis
July 15, 2026 · 16 minIn this episode, Heather Brown, Senior Editor at The Lancet Neurology, chats with Jan Lünemann (University of British Columbia, Canada) and Christian Münz (University of Zürich, Switzerland) about their Rapid Review on Epstein-Barr virus…
-
Hal Dietz discusses the role of genetics in spinal CSF leaks
June 17, 2026 · 16 minIn this episode of In Conversation With, Morgane Boillot, Senior Editor at The Lancet Neurology, speaks with connective tissue disorders — including Marfan syndrome — and human genetics expert Hal Dietz from Johns Hopkins Medicine…
-
Tony Schapira on GBA1 Parkinson's disease
June 16, 2026 · 26 minIn this episode of In Conversation With, Elena Becker-Barroso, Editor-in-Chief of The Lancet Neurology, speaks with movement disorders specialist Tony Schapira from UCL’s Queen Square Institute of Neurology about GBA1-associated…
Show 7 more episodesShow fewer episodes
-
Henry Brodaty and Alice Powell on cognitive resilience and ageing
April 17, 2026 · 23 minJoin The Lancet Neurology’s In Conversation With… as editors Elena Becker-Barroso and Laura Hart welcome Henry Brodaty and Alice Powell from the University of New South Wales (Sydney, Australia) to discuss cognitive resilience and…
-
Niklas Mattsson-Carlgren on the use of biomarkers in the diagnosis and stratification of Alzheimer’s disease
March 18, 2026 · 16 minIn this episode, Laura Hart and Elena Becker-Barroso speak with Niklas Mattsson-Carlgren (Lund University) about the use of blood biomarkers in the diagnosis and stratification of Alzheimer's disease. They discuss two particular plasma…
-
Cristina Tassorelli on migraine prevention
February 18, 2026 · 24 minIn this episode, Senior Editor Morgane Boillot speaks with Professor Cristina Tassorelli (University of Pavia, Italy) about recent advances in migraine prevention. Together with colleagues, Tassorelli has authored a Review in the journal…
-
Inga Zerr and Simon Mead on advances in prion diseases
January 21, 2026 · 30 minOur Editor-in-Chief, Elena Becker-Barroso, speaks with Inga Zerr (DZNE, Göttingen, Germany) and Simon Mead (UCL London, UK) about the latest advances in prion diseases. In collaboration with other experts, Zerr and Mead have authored a…
-
Julia Greenland on azathioprine for early Parkinson’s disease
December 19, 2025 · 15 minHost Morgane Boillot chats with Dr Julia Greenland about a clinical trial of azathioprine in early Parkinson's disease. Click here to read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-44…
-
Ian McKeith on dementia with dementia with Lewy bodies
November 12, 2025 · 17 minIn this episode, host Antonia Eisenkoeck, speaks with Ian McKeith, Emeritus Professor of Old Age Psychiatry at Newcastle University, UK. They delve into the history of dementia with Lewy bodies research, highlighting key milestones and…
-
Ask Nordestgaard on long-term stroke risk in women
October 15, 2025 · 12 minIn this episode, host Laura Hart chats with Ask Nordestgaard (Brigham and Women's Hospital, Boston, USA) about the long-term risk of stroke in healthy women, the role of inflammation and lipoproteins, and how early biomarker screening…
About the show
Explore the latest breakthroughs in brain health and neurological disease through interviews with leading researchers, neurologists, and policy experts. Each episode breaks down complex topics for a broad audience, translating cutting-edge science into practical insights.
Editors at The Lancet Neurology, the world-leading clinical neurology journal, interview the investigators at the forefront of stroke, Alzheimer’s disease, epilepsy, migraine, Parkinson’s disease, multiple sclerosis, sleep disorders, traumatic brain injury, and other neurological challenges.